AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 64 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,608,635 | +315.7% | 107,601 | +128.9% | 0.01% | +400.0% |
| Q3 2022 | $387,000 | -72.3% | 47,002 | -77.8% | 0.00% | -66.7% |
| Q2 2021 | $1,395,000 | +258.6% | 211,723 | +298.9% | 0.00% | +200.0% |
| Q1 2021 | $389,000 | -32.6% | 53,075 | -46.9% | 0.00% | -50.0% |
| Q4 2020 | $577,000 | -27.3% | 99,985 | -35.1% | 0.00% | -50.0% |
| Q2 2020 | $794,000 | +1520.4% | 154,108 | +1046.9% | 0.00% | – |
| Q1 2020 | $49,000 | – | 13,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,986,176 | $12,275,000 | 2.58% |
| Worth Venture Partners, LLC | 454,364 | $2,808,000 | 1.26% |
| Opaleye Management Inc. | 455,600 | $2,816,000 | 0.53% |
| J. Goldman & Co LP | 1,663,229 | $10,279,000 | 0.52% |
| X-Square Capital, LLC | 92,283 | $570,000 | 0.30% |
| NEA Management Company, LLC | 3,952,958 | $24,429,000 | 0.29% |
| Birchview Capital, LP | 40,000 | $247,000 | 0.17% |
| PERSONAL CFO SOLUTIONS, LLC | 23,000 | $142,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 147,574 | $912,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 35,232 | $218,000 | 0.02% |